|
Real-time Estimate
Cboe Europe
12:22:25 28/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,626.00 GBX | -0.12% |
|
-2.11% | +4.71% |
| 08-25 | Citigroup says 'buy' Next, UBS raises Drax | AN |
| 08-21 | Hikma Pharmaceuticals: H1 profitability beat; but needs internal biosimilars for sustained re-rating | ![]() |
| Market Cap | 4.65B 3.99B 3.74B 3.42B 6.45B 444B 6.47B 44.29B 17.31B 224B 17.47B 17.1B 741B | P/E 2026 * |
12x | P/E 2027 * | 10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 6.12B 5.26B 4.92B 4.51B 8.49B 585B 8.51B 58.27B 22.78B 295B 22.99B 22.49B 975B | EV / Sales 2026 * |
1.77x | EV / Sales 2027 * | 1.65x |
| Free-Float |
63.17% | Yield 2026 * |
3.9% | Yield 2027 * | 4.13% |
Last Transcript : Hikma Pharmaceuticals PLC
| 1 day | -0.12% | ||
| 1 week | -2.11% | ||
| Current month | +2.40% | ||
| 1 month | +2.92% | ||
| 3 months | +9.66% | ||
| 6 months | +18.21% | ||
| Current year | +4.71% |
| 1 week | 1,607.8 | 1,664 | |
| 1 month | 1,563 | 1,755 | |
| Current year | 1,187 | 1,762 | |
| 1 year | 1,187 | 1,865 | |
| 3 years | 1,187 | 2,360 | |
| 5 years | 1,174.5 | 2,625 | |
| 10 years | 814.2 | 2,768 |
| Manager | Title | Age | Since |
|---|---|---|---|
Said Darwazah
CEO | Chief Executive Officer | 69 | 01/12/2025 |
Areb Kurdi
DFI | Director of Finance/CFO | - | 26/02/2026 |
| Chief Tech/Sci/R&D Officer | 64 | 26/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 14/10/2005 | |
Khalid Nabilsi
BRD | Director/Board Member | 54 | 15/12/2025 |
Said Darwazah
CHM | Chairman | 69 | 15/05/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/12/25 | Buy | Director | 100,000 | 0.0451% | ||
| 11/11/25 | Buy | Chief Executive Officer | 70,000 | 0.0315% | ||
| 11/11/25 | Buy | Chief Executive Officer | 100,000 | 0.0451% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.12% | -2.11% | -10.82% | -24.90% | 4.65B | ||
| -1.12% | -5.49% | +60.19% | +112.43% | 1,048B | ||
| -1.57% | -0.60% | +50.33% | +59.86% | 640B | ||
| -1.81% | -1.41% | +24.07% | +75.98% | 456B | ||
| -0.10% | -3.33% | +39.12% | +40.11% | 362B | ||
| +0.18% | -2.07% | +22.89% | +37.94% | 295B | ||
| +0.26% | +0.71% | +2.22% | +12.32% | 255B | ||
| -0.76% | +0.75% | +51.75% | +70.45% | 236B | ||
| +1.62% | -0.47% | -16.54% | -53.68% | 204B | ||
| +0.52% | +3.78% | +30.67% | +93.68% | 185B | ||
| Average | -0.30% | -0.62% | +25.39% | +42.42% | 368.63B | |
| Weighted average by Cap. | -0.73% | -1.92% | +38.59% | +65.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.46B 2.97B 2.78B 2.55B 4.8B 331B 4.81B 32.95B 12.88B 167B 13B 12.72B 552B | 3.6B 3.09B 2.89B 2.65B 4.99B 344B 5.01B 34.28B 13.4B 173B 13.52B 13.23B 574B |
| Net income | 412M 354M 331M 303M 571M 39.37B 573M 3.92B 1.53B 19.84B 1.55B 1.51B 65.67B | 453M 389M 364M 334M 629M 43.31B 630M 4.31B 1.69B 21.83B 1.7B 1.67B 72.23B |
| Net Debt | 1.47B 1.26B 1.18B 1.08B 2.04B 140B 2.04B 13.98B 5.46B 70.7B 5.51B 5.4B 234B | 1.29B 1.11B 1.04B 952M 1.79B 124B 1.8B 12.31B 4.81B 62.26B 4.86B 4.75B 206B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | GBX 1,624.00 | -0.25% | 14,831 |
| 27/08/26 | GBX 1,628.00 | -0.73% | 445,434 |
| 26/08/26 | GBX 1,640.00 | 0.00% | 862,660 |
| 25/08/26 | GBX 1,640.00 | +0.43% | 349,026 |
| 24/08/26 | GBX 1,633.00 | -0.18% | 680,937 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HIK Stock
Select your edition
All financial news and data tailored to specific country editions



















